P. L. Shah, F. J. Herth, W. H. Van-geffen, G. Deslee, and D. Slebos, Lung volume reduction for emphysema, Lancet Respir Med, vol.5, pp.147-56, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02451024

D. Makris, S. Leroy, J. Pradelli, J. Benzaquen, H. Guenard et al., Changes in dynamic lung mechanics after lung volume reduction coil treatment of severe emphysema, Thorax, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02450497

P. L. Shah, Z. Zoumot, S. Singh, S. R. Bicknell, E. T. Ross et al., RESET trial Study group. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial, Lancet Respir Med, vol.1, pp.233-240, 2013.

G. Deslée, H. Mal, H. Dutau, A. Bourdin, J. M. Vergnon et al., REVOLENS Study Group. Lung volume reduction coil treatment vs usual Care in Patients with Severe Emphysema: the REVOLENS randomized clinical trial, JAMA, vol.315, pp.175-84, 2016.

F. C. Sciurba, G. J. Criner, C. Strange, P. L. Shah, G. Michaud et al., Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial, JAMA, vol.315, pp.2178-89, 2016.

D. Husereau, M. Drummond, S. Petrou, C. Carswell, D. Moher et al., ISPOR health economic evaluation publication guidelines-CHEERS good reporting practices task force. Consolidated health economic evaluation reporting standards (CHEERS)-explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force, Value Health J Int Soc Pharmacoeconomics Outcomes Res, vol.16, pp.231-50, 2013.

H. Autorité-de-santé, Choix méthodologiques pour l'évaluation économique, 2014.

. Guide, Direction générale de l'offre de soins, 2014.

, Assurance Maladie. Les consultations en métropole

. Ameli and . Fr, , 2017.

A. Maladie, Classification commune des actes médicaux

A. Maladie, Table nationale de codage de biologie, p.2017

. Eco-santé, , 2013.

, Base des médicaments et informations tarifaires, 2013.

, Référentiel de coûts MCO, 2014.

S. Santé, , 2009.

A. Tarifs, . Mco, and . Had, , 2017.

, Tarification de référence

, ATIH, 2016.

, Les dépenses de santé en 2016 -Résultats des comptes de la santé

M. Solidar, , 2017.

C. M. Nolan, L. Longworth, J. Lord, J. L. Canavan, S. E. Jones et al., The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference, Thorax, vol.71, pp.493-500, 2016.

E. ,

. Euroqol, , 2017.

N. Gusi, P. R. Olivares, and R. Rajendram, The EQ-5D Health-Related Quality of Life Questionnaire, Handb. Dis. Burd. Qual. Life Meas, p.87, 2010.

J. B. Pietzsch, A. Garner, and F. Herth, Cost-effectiveness of endobronchial valve therapy for severe emphysema: a model-based projection based on the VENT study, Respir Int Rev Thorac Dis, vol.88, pp.389-98, 2014.

, Study of PneumRx Endobronchial Coil System in Treatment of Subjects With Severe Emphysema (ELEVATE)

. Clinicaltrial and . Gouv, , 2018.